Streamline Genomics

Streamline Genomics is a Montréal-based genomics software company founded in 2017 that develops a secure cloud-based platform intended to democratize precision medicine by helping clinicians and researchers use genomic data to inform treatment options. The company addresses the difficulty physicians face in interpreting the complex data produced when a patient's DNA is sequenced: while sequencing an individual with cancer or a rare disease has become inexpensive, clinicians lack tools to identify the relevant genetic findings for each patient or to keep pace with the thousands of human genomics research papers published each week.

Users of the flagship platform — including oncologists, researchers and analysts — can view genomic sequencing analysis, incorporate an existing knowledge base drawn from open-source and peer-generated data and commentary, and generate actionable insights. The product is positioned to provide rapid clinical decision support in complex fields such as oncology. The company's product roadmap incorporates natural language processing and artificial intelligence projects developed with the help of academic institutions.

Founding story

Founder Dr Josette-Renée Landry holds a Ph.D. in Genetics from the Terry Fox Labs at UBC (2003), completed a postdoctoral fellowship at the University of Cambridge and an MBA from HEC Montréal. She previously served as VP, Business Development at Mitacs, where she facilitated partnerships between university researchers and industry, and during graduate studies co-founded a bioinformatics consulting firm serving the Vancouver biotechnology sector. She has described her mother's breast cancer diagnosis as a personal setback that motivated her to raise funding for cancer research and to leave an executive position to launch the start-up.

Business model

Streamline Genomics offers a cloud-based genomic analysis platform used by clinicians, researchers and analysts to interpret sequencing data and produce clinical decision support.